The neomycine-furazolidone-xanthan complex has been synthesized. Neomycine is covalently linked to xanthan, while furazolidone is inserted in the hydrogel formed by the reaction between neomycine and xanthan. The content of neomycine and furazolidone depends on the drug rate in the reaction medium. Thus, a zero-order kinetics is obtained for the release of both neomycine and furazolidone in basic medium. The complex's antimicrobial activity is intensified.
Get full access to this article
View all access options for this article.
References
1.
Langer, R. and M.A. Peppas.1981. "Present and Future Applications of Biomaterials in Controlled Drug Delivery Systems," Biomaterials , 2:201-204.
2.
Poznansky, J.J. and R.L. Juliano.1984. "Biological Approaches to the Controlled Delivery of Drugs: A Critical Review," Pharmacol. Rev., 36:277-336.
3.
Dumitriu, S. , M.I. Popa and Cr. Simionescu.1986. "Bioactive Polymers XVI. Immobilization of Novocaine on Biozan R," Bull. Soc. Chim. Belg., 95:283-286.
4.
Simionescu, Cr. , S. Dumitriu, M. Popa and M. Dumitriu.1986. "Bioactive Polymers XLII. Coupling of Ampicilline on (Chlorocarbonylmethyl) Cellu. lose," Polym. Bull., 16:319-321.
5.
Dumitriu, S. , M. Popa and M. Dumitriu.1989. "Polymeric Biomaterials as Enzyme and Drug Carriers Part III. Polymeric Drugs and Drug Delivery Systems ," J. Bioact. Comp. Polym., 4:57-73.
6.
Hosaka, S.H. , H. Ozawa and H. Tanzawa.1979. "Controlled Release of Drugs from Hydrogel Matrices," J. Appl. Polym. Sci., 23:2089-2098.
7.
Denizeli, A. , M. Kiremitci and E. Piskin.1988. "Subcutaneous Polymeric Matrix System Poly(HEMA-BGA) for Controlled Release of an Anticancer Drug (5-Fluorouracil) " Biomaterials, 9:363-374.
8.
Brook, J.M., C.W.I. Douglas and R. van Noort.1986. "Controlling Drug Release from Acrylic Polymers: In vitro Studies with Potential Oral Inserts," Biomaterials, 7:292-296.
9.
Heller, J., R.F. Helwing, R.W. Baker and M.E. Tuttle.1983. "Controlled Release of Water-Soluble Macromolecules from Bioerodible Hydrogels," Biomaterials, 4:262-266.
10.
Al-Khamis, K.I., S.S. Davis and J. Hadgraft.1986. "Microviscosity and Drug Release from Topical Gel Formulations," Pharm. Res., 3:214-217.
11.
Shih, C., T. Higuchi and K.J. Himmelstein .1984. "Drug Delivery from Catalysed Erodible Polymeric Matrices of Poly(or-thoesters)s" Biomaterials , 5:237-240.
12.
Langer, R.1980. "Polymeric Delivery Systems for Controlled Release ," Eng. Commun., 6:1-48.
13.
Bodmeier, R. and J.W. McGinity.1988. "Solvent Selection in the Preparation of Poly(DL-Iactide) Microspheres Prepared by the Solvent Evaporation Method" Int. J. Pharm., 43:179-186.
14.
Illum, L., N.W. Thomas andS.S. Davis.1986. "The Effect of a Selected Suppression of the Reticuloendothelial System on the Distribution of Model Carrier Particles," J. Pharm. Sci., 75:16-22.
15.
Trouet, A., D. Deprez-De Campeneere and C. De Duve.1972. "Chemotherapy through Lysosomes with a DNA-Daunorubicin Complex," Nature New Biology, 139:110-112.
16.
Tsukada, Y. , K. Ohkawa and N. Hibi.1985. "Suppression of Human-Foetoprotein-Producing Hepatocellular Carcinoma Growth in Nude Mice by an Anti-Foetoprotein Antibody-Daunorubicin Conjugate with a Poly-L-Glutamic Acid Derivative as Intermediate Drug Carrier ," Br. J. Cancer , 52:111-116.
17.
Ringsdorf, H.1975. "Structure and Properties of Pharmacologically Active Polymers," J. Polymer Sci. Symp ., 51:135-153.
18.
Hashida, M., A. Kato, Y. Takakura and H. Sezaki.1984. "Deposition and Pharmacokinetics of a Polymeric Prodrug of Mitomycin C, Mitomycin C-Dextran Conjugate, Drug Metabolism and Disposition," 1:492-499.
19.
Burns, D.T. , G.H. Lloyd and J.W. Walker.1978. "The Colorimetric Determination of Neomycin," LABP , 17:448-453.
20.
Kelco Company.1976. Xanthan Gum: A Natural Biopolysaccharide for Scientific Water Control , Second Edition.
